Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript
Acadia Healthcare (ACHC) reported Q3 2026 revenue of $895.3M, up 5.1% YoY, driven by patient volume growth and higher revenue per patient day. Adjusted EBITDA rose 2% to $176.4M, while adjusted EPS fell to $0.60 from $0.72. The company raised full-year revenue and EBITDA guidance, citing strong demand for behavioral health services. Management noted challenges from NY Medicaid changes and a tight labor market.
How this was made

The 30-second read
Why it matters
The earnings beat and raised guidance provide a fresh catalyst for short‑term price appreciation, though Medicaid headwinds and startup facility losses temper upside.
Market read
First‑report earnings with improved guidance create actionable trading opportunity for ACHC and may influence peer healthcare stocks.
What to watch
New York Medicaid changes and incremental EBITDA targets could pressure margins.
Background
Acadia Healthcare (ACHC) reported Q3 2026 results, highlighting revenue growth, bed expansion, and revised FY guidance.
Ticker impact
Q3 2026 earnings released with revenue up 5.1% YoY and full-year guidance raised.
likely upward pressure as investors price in higher full-year revenue and EBITDA guidance
Revenue rose to $895.3M, adjusted EPS $0.60, and guidance for FY revenue $3.44‑$3.46B and EBITDA $615‑$625M were increased.
Market effects
Behavioral health sector may see broader optimism from Acadia's guidance lift.
U.S. healthcare stocks could benefit from the positive earnings surprise.
Limited to U.S. markets; no direct global macro effect.
Counterpoint
Higher guidance may already be priced in; focus on Medicaid headwinds and startup losses.
Key entities
- CompanyAcadia Healthcare Company, Inc.
U.S. behavioral health services provider (NASDAQ: ACHC).



